Germany excels in Non-Hodgkin's lymphoma treatment, with clinics accredited by the German Cancer Society (DKG). Institutions like Asklepios Hospital Barmbek, Nordwest Clinic (Krankenhaus), and Düsseldorf Clinics Association offer CAR T-cell therapy, radioimmunotherapy, autologous stem cell transplantation, and targeted therapy. The survival rate for Non-Hodgkin's lymphoma in Germany reaches 70%, with advanced stages achieving high success due to innovative care.
Asklepios Hospital Barmbek, noted by the Medical Travel Quality Alliance, serves 80,000 patients annually, specializing in oncology and oncohematology. Nordwest Clinic (Krankenhaus) is known for 3D ultrasound and anticancer vaccine innovations, supported by five research institutes and 11 centers. Düsseldorf Clinics Association, with 60 professors featured in Focus magazine, treats over 200,000 patients yearly, offering top oncology care.